Effect of neuromodulation on neurotrophic factors in patients with chronic disorders of consciousness
- 23 September 2020
- journal article
- research article
- Published by Pirogov Russian National Research Medical University in Bulletin of Rsmu
- No. 2020(5),p. 37-43
- https://doi.org/10.24075/brsmu.2020.056
Abstract
Transcranial magnetic stimulation (TMS) is one of rehabilitation approaches for patients with chronic disorders of consciousness (DOC). The aim of our study was to assess neurotrophic factors and the changes of those after TMS course in patients with chronic DOC. We enrolled 26 patients with chronic DOC of various etiology and 21 heathy volunteers. Blood serum and cerebrospinal fluid (CSF) were collected from all patients before and after the TMS course, the levels of BDNF, NSE, NGF,.DGF, GDNF and NT3 were assessed in the biomaterial. The blood BDNF, NSE, PDGF, GDNF and NT3 in patients with chronic DOC were higher compared to healthy volunteers (p < 0.05). We found no correlations between the type of DOC and neurotrophic factors concentrations in blood and CSF. The CSF level of BDNF in patients after traumatic brain injury (TBI) was higher compared to patients with non-traumatic chronic DOC (p < 0.05). We also found the increase of CSF BDNF after the TMS course in patients after TBI (p < 0.05). No other significant differences between groups and another blood and cerebrospinal fluid biomarker levels were detected. Thus, the serum BDNF, NSE, PDGF, GDNF and NT3 levels in patients with chronic DOC were higher compared to healthy volunteers. The BDNF level in CSF was higher in patients with traumatic DOC, and it also increased after the course of high-frequency TMS in this group. This fact may indicate the long-term neuronal plasticity processes in patients after TBI, as well as more favorable rehabilitation prognosis.Keywords
Funding Information
- Russian Science Foundation (16-15-00274)
This publication has 26 references indexed in Scilit:
- Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injuryCritical Care, 2012
- Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort studyBMC Cardiovascular Disorders, 2011
- GDNF and protection of adult central catecholaminergic neuronsJournal of Molecular Endocrinology, 2011
- BDNF-Hypersecreting Human Mesenchymal Stem Cells Promote Functional Recovery, Axonal Sprouting, and Protection of Corticospinal Neurons after Spinal Cord InjuryJournal of Neuroscience, 2009
- Expression of Neurotrophin-3 Promotes Axonal Plasticity in the Acute but Not Chronic Injured Spinal CordJournal of Neurotrauma, 2006
- Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patientsJournal of Affective Disorders, 2006
- High-Frequency Repetitive Transcranial Magnetic Stimulation Improves Refractory Depression by Influencing Catecholamine and Brain-Derived Neurotrophic FactorsPharmacopsychiatry, 2006
- Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma ScaleResuscitation, 2005
- Long-Term Repetitive Transcranial Magnetic Stimulation Increases the Expression of Brain-Derived Neurotrophic Factor and Cholecystokinin mRNA, but not Neuropeptide Tyrosine mRNA in Specific Areas of Rat BrainNeuropsychopharmacology, 2000
- Treatment of the Chronically Injured Spinal Cord with Neurotrophic Factors Can Promote Axonal Regeneration from Supraspinal NeuronsExperimental Neurology, 1997